AMPs have shown promising antineoplastic features such as cytotoxicity, antiproliferation, reducing cell adhesion, interfering with tubulins, and anti-angiogenesis in preclinical studies of lung cancer treatment. The gene discussed is ADSL; the disease is lung carcinoma.